Shares of Herbalife Nutrition Ltd (NYSE:HLF) have earned an average rating of “Buy” from the eight analysts that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $41.55.

HLF has been the topic of several recent analyst reports. Citigroup reiterated a “buy” rating and set a $55.00 target price on shares of Herbalife Nutrition in a report on Wednesday, December 4th. ValuEngine upgraded Herbalife Nutrition from a “hold” rating to a “buy” rating in a report on Wednesday, October 30th. Finally, Zacks Investment Research upgraded Herbalife Nutrition from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd.

HLF stock traded down $0.68 during midday trading on Tuesday, hitting $46.15. 1,055,000 shares of the company’s stock were exchanged, compared to its average volume of 900,011. The stock’s fifty day moving average price is $46.46 and its 200-day moving average price is $41.66. The company has a market cap of $6.95 billion, a PE ratio of 16.02 and a beta of 0.49. Herbalife Nutrition has a one year low of $33.62 and a one year high of $61.77.

Herbalife Nutrition (NYSE:HLF) last posted its earnings results on Tuesday, October 29th. The company reported $0.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.09. The firm had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.21 billion. Herbalife Nutrition had a negative return on equity of 65.44% and a net margin of 6.26%. The company’s revenue for the quarter was up .1% on a year-over-year basis. During the same period in the previous year, the company posted $0.74 earnings per share. On average, analysts predict that Herbalife Nutrition will post 2.66 earnings per share for the current fiscal year.

Institutional investors have recently modified their holdings of the company. Parallel Advisors LLC lifted its holdings in shares of Herbalife Nutrition by 152.5% in the third quarter. Parallel Advisors LLC now owns 712 shares of the company’s stock valued at $27,000 after purchasing an additional 430 shares in the last quarter. Doyle Wealth Management bought a new stake in shares of Herbalife Nutrition in the second quarter valued at about $37,000. Gables Capital Management Inc. bought a new stake in shares of Herbalife Nutrition in the third quarter valued at about $76,000. Phocas Financial Corp. bought a new stake in shares of Herbalife Nutrition in the second quarter valued at about $13,286,000. Finally, Point72 Asset Management L.P. bought a new stake in shares of Herbalife Nutrition in the third quarter valued at about $204,000. Institutional investors own 86.10% of the company’s stock.

About Herbalife Nutrition

Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.

Featured Article: What sectors are represented in the Nikkei Index?

Analyst Recommendations for Herbalife Nutrition (NYSE:HLF)

Receive News & Ratings for Herbalife Nutrition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Nutrition and related companies with MarketBeat.com's FREE daily email newsletter.